Annual Total Expenses
$34.42 M
-$31.60 M-47.86%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual total expenses is $34.42 million, with the most recent change of -$31.60 million (-47.86%) on December 31, 2022.
- During the last 3 years, ELOX annual total expenses has fallen by -$16.14 million (-31.92%).
- ELOX annual total expenses is now -47.86% below its all-time high of $66.02 million, reached on December 31, 2021.
Performance
ELOX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$3.64 M
-$503.00 K-12.15%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly total expenses is $3.64 million, with the most recent change of -$503.00 thousand (-12.15%) on September 30, 2023.
- Over the past year, ELOX quarterly total expenses has dropped by -$3.50 million (-49.08%).
- ELOX quarterly total expenses is now -89.82% below its all-time high of $35.73 million, reached on June 30, 2021.
Performance
ELOX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ELOX Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -47.9% | -49.1% |
3 y3 years | -31.9% | -42.2% |
5 y5 years | +80.2% | -74.2% |
ELOX Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -47.9% | at low | -68.7% | at low |
5 y | 5-year | -47.9% | +16.9% | -89.8% | at low |
alltime | all time | -47.9% | -100.0% | -89.8% | +963.8% |
Eloxx Pharmaceuticals Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $3.64 M(-12.1%) |
Jun 2023 | - | $4.14 M(-24.5%) |
Mar 2023 | - | $5.48 M(-9.0%) |
Dec 2022 | $34.42 M(-47.9%) | $6.03 M(-15.6%) |
Sep 2022 | - | $7.14 M(-30.6%) |
Jun 2022 | - | $10.30 M(-6.0%) |
Mar 2022 | - | $10.95 M(-5.8%) |
Dec 2021 | $66.02 M(+124.3%) | $11.63 M(+13.5%) |
Sep 2021 | - | $10.24 M(-71.3%) |
Jun 2021 | - | $35.73 M(+324.6%) |
Mar 2021 | - | $8.41 M(+45.5%) |
Dec 2020 | $29.44 M(-41.8%) | $5.78 M(-8.2%) |
Sep 2020 | - | $6.30 M(-17.0%) |
Jun 2020 | - | $7.59 M(-22.4%) |
Mar 2020 | - | $9.77 M(-14.9%) |
Dec 2019 | $50.55 M(+7.6%) | $11.49 M(-10.1%) |
Sep 2019 | - | $12.78 M(-10.7%) |
Jun 2019 | - | $14.31 M(+19.5%) |
Mar 2019 | - | $11.98 M(-15.1%) |
Dec 2018 | $46.97 M(+145.9%) | $14.11 M(+24.2%) |
Sep 2018 | - | $11.36 M(-17.1%) |
Jun 2018 | - | $13.71 M(+111.2%) |
Mar 2018 | - | $6.49 M(+934.6%) |
Dec 2017 | $19.10 M(+791.4%) | - |
Sep 2017 | - | $627.60 K(+17.7%) |
Jun 2017 | - | $533.00 K(+55.9%) |
Jun 2017 | $2.14 M(-43.5%) | - |
Mar 2017 | - | $341.90 K(-32.6%) |
Dec 2016 | - | $507.50 K(-33.2%) |
Sep 2016 | - | $760.20 K(+9.1%) |
Jun 2016 | $3.79 M(-51.0%) | $696.50 K(-23.3%) |
Mar 2016 | - | $908.10 K(-8.8%) |
Dec 2015 | - | $995.60 K(-16.3%) |
Sep 2015 | - | $1.19 M(+24.3%) |
Jun 2015 | $7.74 M(+10.2%) | $956.50 K(-24.2%) |
Mar 2015 | - | $1.26 M(-51.9%) |
Dec 2014 | - | $2.63 M(-9.3%) |
Sep 2014 | - | $2.89 M(+76.9%) |
Jun 2014 | $7.02 M(+53.1%) | $1.64 M(-23.1%) |
Mar 2014 | - | $2.13 M(+34.0%) |
Dec 2013 | - | $1.59 M(-4.7%) |
Sep 2013 | - | $1.67 M(+67.5%) |
Jun 2013 | $4.59 M(-13.3%) | $995.80 K(-4.6%) |
Mar 2013 | - | $1.04 M(-19.7%) |
Dec 2012 | - | $1.30 M(+4.3%) |
Sep 2012 | - | $1.25 M(+0.1%) |
Jun 2012 | $5.29 M(-13.1%) | $1.25 M(+12.3%) |
Mar 2012 | - | $1.11 M(-33.1%) |
Dec 2011 | - | $1.66 M(+29.4%) |
Sep 2011 | - | $1.28 M(+27.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | $6.09 M(+22.1%) | $1.01 M(-26.3%) |
Mar 2011 | - | $1.37 M(-9.1%) |
Dec 2010 | - | $1.50 M(-31.8%) |
Sep 2010 | - | $2.21 M(+27.6%) |
Jun 2010 | $4.99 M(+9.4%) | $1.73 M(+54.2%) |
Mar 2010 | - | $1.12 M(-2.7%) |
Dec 2009 | - | $1.15 M(+17.2%) |
Sep 2009 | - | $983.70 K(-19.7%) |
Jun 2009 | $4.56 M(+12.4%) | $1.22 M(+14.1%) |
Mar 2009 | - | $1.07 M(-12.7%) |
Dec 2008 | - | $1.23 M(+18.8%) |
Sep 2008 | - | $1.03 M(+5.1%) |
Jun 2008 | $4.06 M(+12.0%) | $984.50 K(-27.1%) |
Mar 2008 | - | $1.35 M(+38.1%) |
Dec 2007 | - | $978.10 K(+31.8%) |
Sep 2007 | - | $742.00 K(-2.0%) |
Jun 2007 | $3.62 M(+3.9%) | $756.90 K(-8.6%) |
Mar 2007 | - | $828.50 K(-38.3%) |
Dec 2006 | - | $1.34 M(+93.9%) |
Sep 2006 | - | $692.60 K(-14.7%) |
Jun 2006 | $3.49 M(+1.1%) | $812.40 K(+4.5%) |
Mar 2006 | - | $777.40 K(-18.5%) |
Dec 2005 | - | $954.20 K(+1.3%) |
Sep 2005 | - | $942.00 K(+8.0%) |
Jun 2005 | $3.45 M(-15.0%) | $872.50 K(-6.6%) |
Mar 2005 | - | $934.50 K(+4.3%) |
Dec 2004 | - | $895.70 K(+20.4%) |
Sep 2004 | - | $744.00 K(-48.1%) |
Jun 2004 | $4.05 M(+77.9%) | $1.43 M(+133.3%) |
Mar 2004 | - | $614.70 K(-31.6%) |
Dec 2003 | - | $898.70 K(-36.3%) |
Sep 2003 | - | $1.41 M(+189.7%) |
Jun 2003 | $2.28 M(-1.5%) | $487.20 K(-8.4%) |
Mar 2003 | - | $532.10 K(-25.3%) |
Dec 2002 | - | $712.10 K(+30.1%) |
Sep 2002 | - | $547.20 K(+23.1%) |
Jun 2002 | $2.31 M(+17.4%) | $444.60 K(-10.3%) |
Mar 2002 | - | $495.50 K(-43.5%) |
Dec 2001 | - | $876.40 K(+76.1%) |
Sep 2001 | - | $497.70 K(+19.8%) |
Jun 2001 | $1.97 M(-19.5%) | $415.60 K(-8.4%) |
Mar 2001 | - | $453.90 K(-21.6%) |
Dec 2000 | - | $579.00 K(+10.8%) |
Sep 2000 | - | $522.60 K(-16.4%) |
Jun 2000 | $2.45 M(+111.7%) | $625.30 K(-24.4%) |
Mar 2000 | - | $827.40 K(+65.5%) |
Dec 1999 | - | $500.00 K |
Jun 1999 | $1.16 M(>+9900.0%) | - |
Jun 1998 | $0.00(0.0%) | - |
Jun 1997 | $0.00 | - |
FAQ
- What is Eloxx Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual total expenses year-on-year change?
- What is Eloxx Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly total expenses year-on-year change?
What is Eloxx Pharmaceuticals annual total expenses?
The current annual total expenses of ELOX is $34.42 M
What is the all time high annual total expenses for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual total expenses is $66.02 M
What is Eloxx Pharmaceuticals annual total expenses year-on-year change?
Over the past year, ELOX annual total expenses has changed by -$31.60 M (-47.86%)
What is Eloxx Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ELOX is $3.64 M
What is the all time high quarterly total expenses for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly total expenses is $35.73 M
What is Eloxx Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, ELOX quarterly total expenses has changed by -$3.50 M (-49.08%)